Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation

被引:105
作者
Citri, A
Gan, J
Mosesson, Y
Vereb, G
Szollosi, J
Yarden, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biophys & Cell Biol, H-4012 Debrecen, Hungary
关键词
ErbB-2/HER2; Hsp90; tyrosine kinase; EGF; signal transduction;
D O I
10.1038/sj.embor.7400300
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ErbB-2/HER2 is an oncogenic tyrosine kinase that regulates a signalling network by forming ligand-induced heterodimers with several growth factor receptors of the ErbB family. Hsp90 and co-chaperones regulate degradation of ErbB-2 but not other ErbB members. Here, we report that the role of Hsp90 in modulating the ErbB network extends beyond regulation of protein stability. The capacity of ErbB-2 to recruit ligand-bound receptors into active heterodimers is limited by Hsp90, which is dissociated from ErbB-2 following ligand-induced heterodimerization. We show that Hsp90 binds a specific loop within the kinase domain of ErbB-2, thereby restraining heterodimer formation and catalytic function. These results define a role for Hsp90 as a molecular switch regulating the ErbB signalling network by limiting formation of ErbB-2-centred receptor complexes.
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 15 条
[1]   Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site [J].
Arteaga, CL ;
Ramsey, TT ;
Shawver, LK ;
Guyer, CA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) :23247-23254
[2]   Drug-induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy [J].
Citri, A ;
Alroy, I ;
Lavi, S ;
Rubin, C ;
Xu, WP ;
Grammatikakis, N ;
Patterson, C ;
Neckers, L ;
Fry, DW ;
Yarden, Y .
EMBO JOURNAL, 2002, 21 (10) :2407-2417
[3]   The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR [J].
Donzé, O ;
Abbas-Terki, T ;
Picard, D .
EMBO JOURNAL, 2001, 20 (14) :3771-3780
[4]   Mechanism of action of erbB tyrosine kinase inhibitors [J].
Fry, DW .
EXPERIMENTAL CELL RESEARCH, 2003, 284 (01) :131-139
[5]   The conformational plasticity of protein kinases [J].
Huse, M ;
Kuriyan, J .
CELL, 2002, 109 (03) :275-282
[6]   MECHANISM OF CDK ACTIVATION REVEALED BY THE STRUCTURE OF A CYCLINA-CDK2 COMPLEX [J].
JEFFREY, PD ;
RUSO, AA ;
POLYAK, K ;
GIBBS, E ;
HURWITZ, J ;
MASSAGUE, J ;
PAVLETICH, NP .
NATURE, 1995, 376 (6538) :313-320
[7]   Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions [J].
PinkasKramarski, R ;
Soussan, L ;
Waterman, H ;
Levkowitz, G ;
Alroy, I ;
Klapper, L ;
Lavi, S ;
Seger, R ;
Ratzkin, BJ ;
Sela, M ;
Yarden, Y .
EMBO JOURNAL, 1996, 15 (10) :2452-2467
[8]   Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery [J].
Pratt, WB ;
Toft, DO .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (02) :111-133
[9]   Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37 [J].
Prince, T ;
Matts, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (38) :39975-39981
[10]   HERBIMYCIN-A INDUCES THE 20S PROTEASOME-DEPENDENT AND UBIQUITIN-DEPENDENT DEGRADATION OF RECEPTOR TYROSINE KINASES [J].
SEPPLORENZINO, L ;
MA, ZP ;
LEBWOHL, DE ;
VINITSKY, A ;
ROSEN, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (28) :16580-16587